Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its Q3 earnings later this week. Experts are predicting strong growth driven by the strong demand of Lilly's blockbuster medications, approved peptide manufacturer. particularly recent launches. However, there are also concerns about potential h